Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Nasal powder drug delivery (CROSBI ID 36125)

Prilog u knjizi | izvorni znanstveni rad

Filipović-Grčić, Jelena ; Hafner, Anita Nasal powder drug delivery // Pharmaceutical Manufacturing Handbook: Production and Processes / Gad, Shayne Cox (ur.). Singapur : London : München : Ženeva : Tokyo : Hong Kong : Taipei : Peking : Šangaj : Tianjin : Chennai: John Wiley & Sons, 2008. str. 651-681

Podaci o odgovornosti

Filipović-Grčić, Jelena ; Hafner, Anita

engleski

Nasal powder drug delivery

Nasal dry powder formulations ; Benefits associated with nasal powder drug delivery Residence time in the nasal cavity, drug concentration at the absorption site, formulation stability ; Drug powder or drug/polymer powder formulation for nasal drug delivery? Drug solubility, absorption, irritability, drug carrier (polymer) ; Powder properties affecting nasal deposition and drug delivery ; Deposition pattern, aerodynamic properties, particle distribution in the nose, particle size, shape, density, flow Polymers in nasal powder delivery system Hydrophilic polymers, functional groups, polymer molecular weight, cross-linking density, swelling ability, transport enhancing effect, bioadhesive properties, new generation mucoadhesive polymers Microspheres as nasal drug delivery devices Drug delivery system, microspheres, polymeric composition, polymer-drug interaction, mucociliary clearance, nasal absorption, bioavailability ; Preparation methods Spray-drying method, emulsification method, emulsion polymerization technique ; Microsphere characterization ; Particle size, morphology, drug content, swelling properties, bioadhesion, drug release profile ; Chitosan formulated spray-dried microspheres ; Chitosan molecular weight, conventional microspheres, composed microspheres, spray-drying parameters, particle size analysis, encapsulation efficiency, physical state of the drug, zeta-potential, tensile studies, swelling studies, in vitro drug release Toxicological considerations Local irritation, tissue damage, epithelial toxicity, ciliotoxicity, mucus turnover, reversible effects

Nasal powder, Drug delivery, Formulation, Polymers, Microspheres, Chitosan, Toxicological considerations

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

651-681.

objavljeno

Podaci o knjizi

Pharmaceutical Manufacturing Handbook: Production and Processes

Gad, Shayne Cox

Singapur : London : München : Ženeva : Tokyo : Hong Kong : Taipei : Peking : Šangaj : Tianjin : Chennai: John Wiley & Sons

2008.

978-0-470-25958-0

Povezanost rada

Farmacija